QNCX – quince therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Quince Therapeutics to Participate at Investor Events in December 2025
Quince Therapeutics (NASDAQ:QNCX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $4.00 price target on the stock.
Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting [Yahoo! Finance]
Form SCHEDULE 13G/A Quince Therapeutics, Filed by: Nantahala Capital Management, LLC
Form 8-K Quince Therapeutics, For: Nov 12
Form 10-Q Quince Therapeutics, For: Sep 30
Form SCHEDULE 13G/A Quince Therapeutics, Filed by: Genextra S.p.A.
Form 8-K Quince Therapeutics, For: Oct 17
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.